This might be the more important (hearing related) news I've read since years...
"New funding supports expanded work to realize the disease modifying potential of Progenitor Cell Activation (PCA™) beyond hearing loss"This might be the more important (hearing related) news I've read since years...
It's important to realize that Frequency is a company built on a tool (PCA). If that tool works for hearing loss, then great. If that tool does not work for hearing loss, they will move on to other diseases/conditions. I believe Will McLean is the only "ear person" among the founders. A company like Decibel is built solely to solve "ear problems" and will likely pursue multiple tools toward this end."New funding supports expanded work to realize the disease modifying potential of Progenitor Cell Activation (PCA™) beyond hearing loss"
I'm not sure this is the news that I was hoping for. So they are basically saying that none of this money will go toward the hearing loss cure.
I understand the concern, but the title of the press release from Frequency is "Frequency Therapeutics Announces $32 Million Series A Financing to Support Clinical Development of a First-in-Class Hearing Restoration Therapeutic"."New funding supports expanded work to realize the disease modifying potential of Progenitor Cell Activation (PCA™) beyond hearing loss"
Yes but would this help for us with tinitus?Well, the sentence before the 2018 statement mentions a treatment to remedy hearing loss and that it may not reach clinic earlier than late 2018. Still doesn't say much, as that might be late 2018 or early 2036 for that matter. It is however a cautiously optimistic statement. The article states that the companies involved are "motivated" and hence working hard to get a treatment to market. This confirms my earlier thoughts that the race is on.
If a treatment indeed comes to market in 2018, do not expect it to be perfect. Probably it will offer modest improvements as it is a first try at an effective treatment, but these might be just enough for a lot of us here.
I would like to say to you that you (and we) live in an interesting time to have hearing loss if you have it. For decades there hasn't been so much activity and motivation in this field to get something useful out there.
Yes but would this help for us with tinitus?
What is unfortunate about their choice of words is that it implies that there will be a treatment in a clinic in the next 18 months. While this is perhaps technically correct if you think of a clinical trial as being a treatment in a clinic, it gives the impression that there will be an actual treatment that you could go to your doctor and receive in the next 18 months, and that isn't the case at all.but the simple fact that chronic noise induced hearing loss might be treated in clinic in a few months is groundbreaking news anyway
To what extent will it fail? How probable is this failure? Do you happen to know something about this?we all know it can fail (and probably will to some extent, if not completely)
The co-founder of frequency therapeutics is a redditor and he's talked about tinnitus on reddit.com/r/tinnitus and reddit.com/r/science often.
@Alue /u/the-leviathan . I've been reading his user history seems now and even when he was early into his PhD. he has always thought strongly that tinnitus could be reversed through hearing cell regeneration. His optimism gives me optimism.
Is there any way to invite him onto this forum thread acufenero? So we can bombard him with questions?
Is there any way to invite him onto this forum thread acufenero? So we can bombard him with questions?
They're the dealI have been in contact with Dr. McLean two weeks ago. He is the co-founder and vice president of Frequency Therapeutics. He seemed pretty confident about the work they're doing. I won't quote him here word for word, I will just give you the gist of it.
- Regenerating hair cells may be helpful in patients suffering from tinnitus accompanied by hearing loss.
- Tinnitus accompanied by hearing loss may be the result of the brain filling in input for a signal that is lost (eg. missing hair cells and/or neurons in a certain cochlear region).
- Research has found that providing more input can dampen tinnitus.
- They are still on track for the clinical trial start date mentioned in the articles.
- The progenitor cells are a subset of supporting cells that express a gene called Lgr5.
- The hair cells they make in a dish show that they have all the characteristics to function properly. They have long bundles, function electrically, and make the synapse components to connect to hair cells.
- They can make and restore both inner and outer hair cells.
- In development it is the hair cells and supporting cells that release the proteins to attract neurons (NT3, BDNF). Their research shows that regenerated hair cells make the synapse components to communicate with neurons, even if neurons are not present.
- They suspect that there will be several approaches that may be tailored to the cause of a person's hearing loss.
- Their work suggests that starting the regeneration process allows supporting cells and hair cells to restart the synapse formation process. If a person has all of their hair cells, this may not be the best option.
- Their analysis of donated cochleas from patients suggest that hair cells are the primary drivers of hearing loss.
- They are actively exploring the direct role of drugs on neurons.
- They acknowledge that there isn't yet a good system to diagnose "synapse only" conditions in the clinic.